A call from a Puget Sound memory care community about agitation often ends with a proposed prescription. Here are the questions Washington families should ask first, and the rights that sit behind them.
By Patricia Nguyen, CDP · September 08, 2026
It usually comes a few weeks after a move. Your mother is up at night, resisting help with bathing, or shouting at a staff member she does not recognize. The community calls, the tone is concerned rather than alarmed, and somewhere in the conversation a medication is suggested to help her settle.
This is one of the most consequential decisions a family makes in memory care, and it is usually made in a five-minute phone call while you are at work. It is entirely reasonable to say: I want to understand what is happening before we medicate it. Nothing about that request is obstructive, and any good community will already be expecting it.
Antipsychotic medications, the group most often proposed for agitation and aggression in dementia, carry an FDA boxed warning: in older adults with dementia-related psychosis, they are associated with an increased risk of death. No antipsychotic is FDA-approved specifically to treat dementia-related psychosis, so these prescriptions are written off-label. That does not make them always wrong. It does mean the benefit has to be worth a real, named risk, and that the decision belongs to the prescribing clinician with your informed participation, not to a scheduling problem on the evening shift.
Other classes have their own trade-offs. Benzodiazepines are associated with falls, sedation, and confusion in older adults. Sedating antihistamines and some sleep medications have anticholinergic effects that can worsen thinking in someone who already has dementia. If a medication is proposed, ask which class it belongs to and what specifically it is being asked to do.
Sudden agitation in a person with dementia is frequently a symptom, not a personality change. Urinary tract infections, constipation, dehydration, undertreated pain from arthritis or a healing fracture, a new medication interaction, poor sleep, a hearing aid with a dead battery, or an untreated dental problem all present as restlessness or resistance because the person cannot describe what hurts.
Delirium is the one to rule out first, especially in the weeks after a hospital stay. It comes on over hours or days, tends to fluctuate, and is a medical event that deserves evaluation rather than sedation. If the change was fast, say so plainly and ask for a medical workup before a prescription.
Then look at the environment. Many so-called behaviors track to a pattern: a shower at a time of day she has never bathed, a roommate's television, a hallway that gets loud at shift change, late-afternoon light and fatigue, or an unmet need for movement. A community with a Specialized Dementia Care endorsement should be able to tell you what they have already tried, when the behavior happens, and what preceded it each time.
What exactly is the behavior, at what time of day, and how often? Vague reports of agitation are hard to evaluate and hard to measure improvement against. What non-drug approaches have been tried, for how long, and what happened? What is the specific goal of this medication, and how will we know within two weeks whether it worked?
Who is prescribing, and have they personally evaluated her? Has delirium, infection, pain, and constipation been ruled out first? What is the lowest starting dose, and what are the side effects staff will watch for, particularly sedation, stiffness, and falls? And critically: when will we review whether to reduce or stop it? A medication started during a crisis should have a planned reassessment date, not an indefinite renewal.
Ask that the answers go in writing into the care plan, and ask to be included in the next care conference. Families who ask for a stop-and-review date tend to get one.
Residents of Washington long-term care settings, including assisted living communities and adult family homes, have rights under RCW 70.129, among them the right to be informed about their care and treatment and to participate in planning it, and the right to be free from chemical restraint used for discipline or staff convenience rather than for the resident's own medical need. In nursing homes, federal and state standards likewise prohibit unnecessary drugs and require that psychoactive medications be clinically justified, monitored, and reduced when possible.
Informed consent belongs to the resident, or to whoever holds legal authority to make health care decisions for her, typically a health care power of attorney or a court-appointed guardian. A community cannot simply add an antipsychotic without that consent process happening. If you are the decision maker, make sure the prescriber has your contact information and knows to reach you directly.
If you cannot get a straight answer, Washington's Long-Term Care Ombudsman program advocates for residents free of charge at 1-800-562-6028. Concerns about care quality or safety in a licensed setting can be reported to DSHS Residential Care Services at 1-800-562-6078. Inspection and complaint history for licensed Washington homes is public and searchable at fortress.wa.gov/dshs/adsaapps/lookup, and for skilled nursing facilities, Medicare's Care Compare publishes each facility's long-stay antipsychotic use rate, which is a fair thing to ask a nursing home about during a tour.
Sometimes it is. A person whose distress is genuinely unrelenting, who is frightened by hallucinations, or whose aggression puts herself or others at real risk may suffer more without treatment than with it. Dementia care is not improved by refusing every prescription on principle, and staff who are managing an unsafe situation deserve a real plan rather than a lecture.
The goal is a considered decision: causes ruled out, non-drug approaches genuinely tried, a specific target, the lowest effective dose, monitoring, and a date to revisit. That is the standard good Puget Sound memory care communities already hold themselves to, and asking for it in writing is a normal part of being an involved family.
If these conversations keep going badly, that is information about the community, not just the medication. Memory care in the Puget Sound region generally runs about $7,500 to $9,500 a month, and families do move when a placement is not working. A licensed adult family home, typically about $4,500 to $7,000 a month with as few as six residents, is sometimes a better fit for someone whose distress is driven by noise and crowding. A local advisor can help you compare options by care level, dementia experience, and Apple Health acceptance.
Free, no-pressure call. We work for families, not facilities.
Or call (253) 893-4164